InvestorsHub Logo
Followers 0
Posts 13277
Boards Moderated 0
Alias Born 05/06/2016

Re: None

Friday, 03/04/2022 6:37:37 AM

Friday, March 04, 2022 6:37:37 AM

Post# of 4862
New White House policy is anti-cannabis.

This was unexpected and not at all how Biden portrayed his views on cannabis while campaigning for office. They are labeling everyone who invests in cannabis-related businesses as potentially having poor judgment and a propensity for criminal behavior.

The Biden administration has expanded its employee conduct guidelines to potentially deny security clearance to individuals who have invested in companies that are involved in the marijuana business, according to an internal executive branch presentation shared with POLITICO.

“Eligibility may be negatively impacted if an individual knowingly and directly invests in stocks or business ventures that specifically pertain to marijuana growers and retailers,” according to the document. “Decisions to willfully invest in such activity could reflect questionable judgment and an unwillingness to comply with laws, rules, and regulations.”

The new “clarifying guidance” was presented in a memo to agency heads in December from Avril Haines, the director of national intelligence, as GovExec reported in January. The presentation noted that any marijuana-related investment “through a diversified mutual fund that is publicly-traded on a U.S. exchange” should be presumed to have been made unwittingly. At the same time, the presentation ended with a warning graphic that states: “NOT KNOWING IS NOT AN EXCUSE.” The new guidance also states that “divestment or disassociation of willful, direct investment in such activities should be considered a mitigating factor.”

What isn’t clear, however, are which marijuana stocks the White House is referring to. American marijuana companies are not traded on U.S. exchanges, because they are not federally legal companies. Instead, U.S.-based marijuana companies trade on the Canadian securities exchange, a lower–tier stock exchange in a country where cannabis is federally legal. Any cannabis companies traded on U.S. exchanges are either selling only legal CBD products or are manufacturing and selling marijuana in a country where it is federally legal, like Canada. The White House and the Office of the Director of National Intelligence declined to clarify this language.